AOX1 and nonpapillary renal cell carcinoma: Four out of the 20 examined CpG sites have significantly higher methylation levels in ccRCC patients with lower AOX1 mRNA expression (Figure 6D), and the methylation levels of these four CpG sites are negatively correlated with AOX1 mRNA expression (Figure 6E).